Nasus Pharma Ltd. Filing Effectiveness Noted by SEC
Ticker: NSRX · Form: EFFECT · Filed: Apr 1, 2026 · CIK: 0002029039
Sentiment: neutral
Topics: filing-effectiveness, sec-filing, pharmaceutical
TL;DR
SEC says Nasus Pharma's filing is officially effective as of 3/31/26. Big news for them.
AI Summary
Nasus Pharma Ltd. filed an EFFECT form with the SEC on April 1, 2026, indicating the effectiveness of a filing related to Act 33, File No. 333-293950. The effectiveness date is March 31, 2026. The company's mailing and business address is 29 Harakevet St, Tel Aviv-Yafo, Israel.
Why It Matters
This filing signifies that a previous submission by Nasus Pharma Ltd. has been officially recognized and approved by the SEC, potentially paving the way for future corporate actions or offerings.
Risk Assessment
Risk Level: low — This is a procedural filing confirming effectiveness, not indicating financial distress or significant new risks.
Key Numbers
- 2026-04-01 — Filing Acceptance Date (Date the SEC accepted the filing.)
- 2026-03-31 — Effectiveness Date (Date the filing became officially effective.)
- 333-293950 — File Number (Specific SEC file number associated with the filing.)
Key Players & Entities
- Nasus Pharma Ltd (company) — Filer
- SEC (company) — Regulatory body
- 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003 (location) — Company Address
FAQ
What type of filing was made effective by Nasus Pharma Ltd?
The filing made effective was a Form EFFECT, which is a Notice of Effectiveness.
When did the SEC filing become effective?
The filing became effective on March 31, 2026.
What is the CIK number for Nasus Pharma Ltd?
The CIK number for Nasus Pharma Ltd is 0002029039.
Where is Nasus Pharma Ltd located?
Nasus Pharma Ltd is located at 29 Harakevet St, Tel Aviv-Yafo, Israel.
What is the SIC code for Nasus Pharma Ltd?
The SIC code for Nasus Pharma Ltd is 2834, which falls under Pharmaceutical Preparations.
Filing Stats: 36 words · 1 min read · ~1 pages · Grade level 12 · Accepted 2026-04-01 00:15:28
Filing Documents
- primary_doc.html (EFFECT)
- primary_doc.xml (EFFECT) — 1KB
- 9999999995-26-001019.txt ( ) — 2KB
From the Filing
Notice of Effectiveness UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: March 31, 2026 Submission Type: POS AM CIK: Company Name: Nasus Pharma Ltd File Number: 333-293950